Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial

Michael Simons, Brian H. Annex, Roger J. Laham, Neal Kleiman, Timothy Henry, Harold Dauerman, James E. Udelson, Ernesto V. Gervino, Marilyn Pike, M. J. Whitehouse, Thomas Moon, Nicolas A. Chronos

Research output: Contribution to journal › Article › peer-review

601 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences